Luis Ostrosky-Zeichner, MD

Professor of Medicine
University of Texas Health Science Center, Houston
Houston, TX, United States

AbbVie/Abbott (Individual(s) Involved: Self): Speakers' bureau; Amplyx (Individual(s) Involved: Self): Consultant; Cidara (Individual(s) Involved: Self): Consultant; F2G (Individual(s) Involved: Self): Consultant; Gilead (Individual(s) Involved: Self): Speakers' bureau; Pfizer (Individual(s) Involved: Self): Other Financial or Material Support, Pfizer, Speakers' bureau; Viracor (Individual(s) Involved: Self): Consultant

Presentation(s):

• 95 - Impact of Penetrating Trauma on Surgical Site Infection Standardized Infection Ratio (SIR) for Colon Procedures

  On Demand

• 123 - Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI)

  On Demand

• Panel Discussion: Research Career Perspectives

  On Demand